Blockade of nitric-oxide synthase reduces choroidal neovascularization

Molecular Pharmacology

Volumn 62, Issue 3, 2002, Pages 539-544

  Ando, Akira ^a,b   Yang, Amy ^a   Nambu, Hiroyuki ^a   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUCH MEMBRANE; CHOROID; CONTROLLED STUDY; DRUG SELECTIVITY; ENDOTHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA ISCHEMIA; SUBRETINAL NEOVASCULARIZATION; TRANSGENIC MOUSE;

ANIMALS; BRUCH MEMBRANE; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; ISCHEMIA; ISOENZYMES; LYMPHOKINES; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; RETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036765588     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.3.539     Document Type: Article

References (45)

1. Ando A, Yang A, Mori K, Yamada H, Yamada E, Takahashi K, Saikia J, Kim M, Melia M, Fishman M, et al. (2002) Nitric oxide is proangiogenic in the retina and choroid. J Cell Physiol 191:116-124.
2. Campochiaro PA (2000) Retinal and choroidal neovascularization. J Cell Physiol 184:301-310.
3. Fischer S, Clauss M, Wiesnet M, Dieter R, Schaper W, and Karliczek GF (1999) Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am J Physiol 276:C812-C820.
4. Fischer AJ and Stell WK (1999) Nitric oxide syntase containing cells in the retina, pigmented epithelium, choroid and sclera of the chick eye. J Comp Neurol 405:1-14.
5. Furchgott RF and Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond) 288:373-376.
6. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, and Ziche M (1998) Role of nitric oxide in angiogenesis and tumor progression in head and neck. J Natl Cancer Inst 90:587-596.
7. Goureau D, Hicks D, Courtois Y, and Kozak YD (1994) Induction and regulation of nitric oxide synthase in retinal Muller cells. J Neurochem 63:310-317.
8. Goureau O, Lepoivre M, Becquet F, Hartmann MP, and Courtois Y (1993) Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cell: in verse correlation with cellular proliferation. Proc Natl Acad Sci USA 90:4276-4280.
9. Guyer DR, Martin DM, Klein M, Haller J, The Eye-Tech Study Group (2001) Anti-VEGF therapy in patients with exudative age-related macular degeneration. Invest Ophthalmol Vis Sci (Suppl) 42:S522.
10. Hatjikondi O, Ravazoula P, Kardamakis D, Dimopoulos J, and Papaioannou S (1996) In vivo experimental evidence that the nitric oxide pathway is involved in the X-ray-induced antiangiogenecity. Br J Cancer 74:1916-1923.
11. Huang PL, Dawson TM, Bredt DS, Snyder SH, and Fishman MC (1993) Targeted disruption of the neuronal nitric oxide synthetase gene. Cell 75:1273-1286.
12. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, and Fishman MC (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthetase. Nature (Lond) 377:239-242.
13. G-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am J Pathol 155:1381-1390.
14. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, and Moncada S (1995) Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92;4392-4396.
15. Jia L, Wu CC, Guo W, and Young X (2000) Antiangiogenic effects of S-nitrosocaptopril crystal as a nitric oxide donor. Eur J Pharmacol 391:137-144.
16. Klein R, Klein BEK, Moss SE, Davis MD, and DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-526.
17. Kone BC (2001) Molecular biology of natriuretic peptides and nitric oxide syntheses. Cardiovasc Res 51:429-441.
18. Ku DD, Zaleski JD, Liu S, and Brock TA (1993) Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265: H586-H592.
19. Kwak N, Okamoto N, Wood JM, and Campochiaro PA (2000) VEGF is an important stimulator in a model of choroidal neovascularization. Invest Ophthalmol Vis Sci 41:3158-3164.
20. Laubach VE, Shesely EG, Smithies O, and Sherman PA (1995) Mice lacking inducible nitric oxide synthetase are not resistant to lipopolysaccharide-induced cell death. Proc Natl Acad Sci USA 92:10688-10692.
21. 3 integrin expression on endothelial cells. Microvasc Res 60:269-280.
22. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, and Koch AE (1994) Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci USA 91:4190-4194.
23. Lloyd PG, Yang HT, and Terjung RL (2001) Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide. Am J Physiol 281:H2528-H2538.
24. Moncada S, Palmer RMJ, and Higgs EA (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142.
25. Montrucchio G, Lupia E, de Martino A, Battaglia E, Arese M, Tizzani A, Bussolino F, and Camussi G (1997) Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. Am J Pathol 151:557-563.
26. Mori K, Ando A, Gehlbach P, Nesbitt D, Takahaski K, Goldsteen D, Penn M, Chen T, Mori K, Melia M, et al. (2001a) Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. Am J Pathol 159:313-320.
27. Mori K, Duh E, Gehlbach P, Ando A, Takahaski K, Pearlman J, Mori K, Yang HS, Zack DJ, Ettyreddy D, et al. (2001b) Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol 188:253-263.
28. Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM, and Snyder SH (1995) behavioral abnormalities in male mice lacking neuronal nitric oxide synthetaze. Nature (Lond) 378:383-386.
29. Norrby K (1998) Nitric oxide suppresses bFGF- and IL-1-alpha-mediated but not VEGF165-mediated angiogenesis in natively vascularized mammalian tissue. AP-MIS 106:1142-1148.
30. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, and Campochiaro PA (1997) Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 151:281-291.
31. Ozaki H, Seo M-S, Ozaki K, Yamada H, Yamada E, Hofmann F, Wood J, and Campochiaro PA (2000) Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol 156:679-707.
32. Park C-S, Pardhasaradhi K, Gianotti C, Villegas E, and Krishna G (1994) Human retina expresses both constitutive and inducible isoforms of nitric oxide synthase mRNA. Biochem Biophys Res Commun 205:85-91.
33. Pipili-Synetos E, Haralabopoulos G, Andriopoulou P, Peristeris P, and Maragoudakis ME (1994) Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 111:894-902.
34. Pipili-Synetos E, Papageorgiou A, Sakkoula E, Sotiropoulou G, Fotsis T, Karakiulakis G, and Maragoudakis ME (1995) Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br. J Pharmacol 116:1829-1834.
35. Powell JA, Mohamed SN, Kerr JS, and Mousa SA (2000) Antiangiogenesis efficacy of nitric oxide donors. J Cell Biochem 80:104-114.
36. Sennlaub F, Courtois Y, and Goureau O (1999) Nitric oxide synthase-II is expressed in severe corneal alkali burns and inhibits neovascularization. Invest Ophthalmol Vis Sci 40:2773-2779.
37. Seo M-S, Kwak N, Ozaki H, Yamada H, Okamoto N, Fabbro D, Hofmann F, Wood JM, and Campochiaro PA (1999) Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am J Pathol 154:1743-1753.
38. Smith LEH, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, and D'Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111.
39. Schwartz SD, Blumenkranz M, Rosenfeld PJ, Miller JW, Haller J, Fish G, Lobes L, Singerman L, Green WL, Reimann J (2001) Safety of rhuFab V2, an anti-VEGF antibody fragment, as a single intravitreal injection in subjects with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (Suppl) 42:522S.
40. Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, and Campochiaro PA (1998a) Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 39:180-188.
41. Tobe T, Ortega S, Luna L, Ozaki H, Okamoto N, Derevjanik NL,Vanores SA, Basilico C, and Campochiaro PA (1998b) Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 153:1641-1646.
42. Verbeke G and Molenberghs G (2000) Linear Mixed Models for Longitudinal Data, Springer-Verlag, Inc., New York.
43. Yamamoto R, Bredt DS, Snyder SH, and Stone RA (1993) The localization of nitric oxide synthetase in the rat eye and related cranial ganglia. Neuroscience 54:189-200.
44. Ziche M, Morbidelli L, Choudburi R, Zhang H-T, Donnini S, Granger HJ, and Bicknell R (1997) Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99:2625-2634.
45. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi SA, Geppetti P, and Ledda F (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Investig 94:2036-2044.